{
  "id": 3276453,
  "title": "FDA approves Jazz’s Ziihera for HER2+ gastric cancer treatment",
  "url": "https://urgent.news/2026/08/25/fda-approves-jazzs-ziihera-for-her2-gastric-cancer-treatment",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-25T14:04:35.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/company-news/fda-approves-jazzs-ziihera-for-her2-gastric-cancer-treatment-93CH-4875591"
  },
  "original_language": "en",
  "account": null,
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 5,
    "also_reported_by": [
      {
        "outlet": "Financial Post",
        "title": "U.S. FDA Approves Ziihera® (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma",
        "url": "https://urgent.news/2026/08/25/u-s-fda-approves-ziihera-zanidatamab-hrii-with-and-without",
        "published": "2026-08-25T14:24:13.000Z"
      },
      {
        "outlet": "Endpoints News",
        "title": "FDA approves Jazz's Ziihera in frontline gastric cancer",
        "url": "https://urgent.news/2026/08/25/fda-approves-jazzs-ziihera-in-frontline-gastric-cancer",
        "published": "2026-08-25T14:37:56.000Z"
      },
      {
        "outlet": "Investing.com",
        "title": "FDA approves Tevimbra combo for HER2+ gastric cancer treatment",
        "url": "https://urgent.news/2026/08/25/fda-approves-tevimbra-combo-for-her2-gastric-cancer-treatment",
        "published": "2026-08-25T14:44:35.000Z"
      },
      {
        "outlet": "Seeking Alpha News",
        "title": "Jazz wins FDA nod for cancer therapy developed with BeOne, Zymeworks",
        "url": "https://urgent.news/2026/08/25/jazz-wins-fda-nod-for-cancer-therapy-developed-with-beone-zymeworks",
        "published": "2026-08-25T14:46:26.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}